Clinical Trial Update: Siplizumab in T1DM [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of siplizumab for Type 1 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Siplizumab (siplizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: TERMINATED